Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Primers for diagnosing ankylosing spondylitis, and method for diagnosing ankylosing spondylitis using the same

An ankylosing spondylitis and primer set technology, applied in the field of primers for the diagnosis of ankylosing spondylitis, can solve the problems of huge exploration and discovery work

Inactive Publication Date: 2012-10-31
韩国科学技术研究院欧洲研究所
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Thus, the discovery effort for biomarkers for early AS diagnosis, prognosis and / or tracking its progression is vast

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primers for diagnosing ankylosing spondylitis, and method for diagnosing ankylosing spondylitis using the same
  • Primers for diagnosing ankylosing spondylitis, and method for diagnosing ankylosing spondylitis using the same
  • Primers for diagnosing ankylosing spondylitis, and method for diagnosing ankylosing spondylitis using the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Example 1. Extension of the VH gene

[0063] After collecting blood from AS patients and normal controls, PBMC (peripheral blood mononuclear cells) and serum were extracted by density gradient centrifugation using a separation medium (Histopaque-sigma, UK) and collected. Perform cDNA synthesis. Subsequently, the VH (variable region of immunoglobulin heavy chain) in each sample was extended from the synthesized cDNA using the VH forward primer and the JH (immunoglobulin heavy chain joining region) reverse primer. Primers are designed based on commonly used primers so that the human VH gene is extended from cDNA (Fan et al., (2003) Clinical Trial Immunology, 131 (2): 364-376 (Van et al., (2003) Clin. Exp.Immunol.131(2):364-376)), by comparing with Immunoglobin Blast HumanVH germline gene sequence (Immunoglobin Blast HumanVH germline gene sequence), adding 3 kinds of primers (with SEQ ID NO: 6 , primers of SEQ ID NO: 7 and SEQ ID NO: 13).

[0064] Table 1

[0065] [s...

Embodiment 2

[0071] Example 2: Transformation of VH2* into bacteria

[0072] The VH2* and PIT2 phagemid vectors obtained in Example 1 were mixed with 4 μl of restriction enzyme NcoI in 100 μl of the total reaction mixture. After incubation at 37°C for 4 hours and purification, 4 μl of restriction enzyme XhoI was added and incubated at 37°C for 4 hours, followed by agarose gel electrophoresis and DNA was isolated by thermal extraction technique.

[0073] Treat the PIT2 phage vector with NcoI and XcoI, add 2 μl of phosphatase, incubate at 37° C. for 1 hour, and then purify. 3 μl of restriction enzyme-cleaved VH2* fragment, and 4 μl of restriction enzyme- and phosphatase-treated PIT2 phagemid vector were added to 20 μl of the total reaction mixture, and 1 μl of ligase was mixed with them , and then the reaction mixture was incubated at 16°C for 18 hours. The incubated reaction mixture was purified and inserted into E. coli TG1 strain by electroporation.

[0074] The reaction conditions o...

Embodiment 3

[0075] Example 3: Sequence Analysis of Transformed Bacterial Strains

[0076] The transformed bacterial strain containing the recombinant DNA obtained in Example 2 was grown on an agar plate containing ampicillin and screened. After screening the transformed strains and culturing them in LB medium for 16 hours, the recombinant DNA in the transformed strains was purified and sequenced with LBM3 primers (with SEQ ID NO: 14; 5'-CAG GAA ACA GCT ATG AC- 3' to identify VH2* fragments in recombinant DNA).

[0077] Insertion of the VH2* fragment into the recombinant DNA was confirmed by DNA sequencing of clones screened by colony polymerase chain reaction. Colony PCR was performed under the same conditions using the primer set for VH2* extension in Example 1 above, and colonies grown on ampicillin-containing media were screened and used as templates DNA.

[0078] After electrophoresis of the PCR products, DNA clones with the predicted size were screened. Such as figure 2 As sh...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to primer sets for diagnosing ankylosing spondylitis and the method for diagnosing ankylosing spondylitis using the same. Particularly, the present invention provides primer sets for diagnosing ankylosing spondylitis as follows: (a) a primer set comprising a primerhaving at least 95% sequence homology with SEQ ID NO: 7, and at least one primer selected from the group consisting of primers of SEQ ID NOs: 9 to 13; (b) a primer set comprising at least one primer selected from the group consisting of primers of SEQ ID NOs: 15 to 17, and a primer having at least 95% sequence homology with SEQ ID NO: 19 and (c) a primer set comprising a primer having at least 95% sequence homology with SEQ ID NO: 18, and a primer having at least 95% sequence homology with SEQ ID NO: 20.; The primer sets and the kit for diagnosing ankylosing spondylitis of the present invention can be effectively used for early diagnosis, tracking progress and prognosis of ankylosing spondylitis.

Description

technical field [0001] The present invention relates to a primer for diagnosing ankylosing spondylitis, and a method for diagnosing ankylosing spondylitis using the primer. Background technique [0002] Ankylosing spondylitis (AS) is a type of severe progressive spondyloarthropathy (Severely progressive Spondyloarthropathy, SpA), which is a chronic progressive systemic disease, characterized in that it starts in late juvenile late teenager) to early twenties, and in the thirties and forties show symptoms such as typical ankylosis of the spondylolisthesis, chronic inflammation of the sacroiliac joints and spine, Symptoms such as invasion into peripheral joints, eyes, heart or intestines. [0003] The prevalence of SpA varies by country but is usually 1-2%. SpA restricts the patient's activities while causing negative social and economic impacts. Recently, based on the accumulation of new knowledge about the progression and treatment of SpA, it has been reported that early ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/11C12Q1/68
CPCC12Q2600/156C12Q1/6883C12Q2600/158C12Q2600/118
Inventor 南昌勋金延柱白翰周
Owner 韩国科学技术研究院欧洲研究所
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com